Abstract: A logic circuit consists of a first transistor network and a complementary second transistor network connected at a central node. The central node serves as a first logic output. Each of the transistor networks is also connected to a respective root. A third transistor network is connected between an intermediate node of one of the transistor networks and the network's respective root. For a nonhomogeneous graft, the third transistor network has a complementary structure to the transistors between the intermediate node and the central node, is of the opposite transistor type as the given transistor network, and has equivalent inputs relative to the transistors between the intermediate node and the central node.
Type:
Application
Filed:
June 27, 2005
Publication date:
December 29, 2005
Applicant:
Technion Research & Development Foundation Ltd.
Abstract: An isolated molecule which comprises an antibody specifically bindable with a binding affinity below 20 nanomolar, preferably below 10 nanomolar, to a human major histocompatibility complex (MHC) class I being complexed with a HLA-restricted antigen and optionally further comprises an identifiable or therapeutic moiety conjugated to the antibody.
Type:
Application
Filed:
August 15, 2005
Publication date:
December 29, 2005
Applicant:
Technion Research & Development Foundation Ltd.
Abstract: Data filtering apparatus comprising: an input for receiving a stream of data, each data item taking a range of at least two values ranging between a low value to a high value, a segmentation device for dividing the stream into segments, a segment midpoint definer for defining a midpoint of each segment, a segment orderer for ordering the segment in a first direction from low to high on a first side of the midpoint and in a second direction from low to high on a second side of the midpoint, an extremity filter unit for comparing the ordered data on either side of the midpoint to create a temporary output per segment, for each segment, each data item on either side of the midpoint being given an extremity filter value, the filter unit being operable to utilize the ordering to find the extremity value via a minimal number of comparisons, the extremity filter for initially comparing a single end of each segment, and being operable to alternate between ends per segment, the extremity filter being further operable
Type:
Grant
Filed:
June 25, 2001
Date of Patent:
October 4, 2005
Assignee:
Technion Research & Development Foundation Ltd.
Abstract: A microelectronic network is fabricated on a fibrous skeleton by binding or complexing electronically functional substances to the nucleic acid skeleton. The skeleton comprises fibers with nucleotide chains. The assembly of the fibers into a network is based on interactions of nucleotide chain portions of different fibers.
Type:
Grant
Filed:
January 28, 1999
Date of Patent:
September 20, 2005
Assignee:
Technion Research & Development Foundation Ltd.
Inventors:
Erez Braun, Yoav Eichen, Uri Sivan, Gdalyahu Ben-Joseph
Abstract: Apparatus for obtaining 3-Dimensional data of a geometric body for matching, and particularly for use in facial matching, comprises a three dimensional scanner for obtaining three-dimensional topographical data of the body, a triangulator for receiving or forming said data into a triangulated manifold, a geodesic converter, for converting the triangulated manifold into a series of geodesic distances between pairs of points of the manifold, and a multi-dimensional scaler, for forming a low dimensional Euclidean representation of the series of geodesic distances, to give a bending invariant representation of the geometric body. In one variant, matching is carried out by taking the principle eigenvalues from the representation and plotting as co-ordinates in a feature space. Tilted or different expression versions of the same face tend to form clusters in the feature space allowing for matching. The apparatus preferably uses the fast marching method for the triangulated domain to obtain the geodesic distances.
Type:
Grant
Filed:
October 31, 2002
Date of Patent:
September 20, 2005
Assignee:
Technion Research & Development Foundation Ltd.
Inventors:
Alexander Bronstein, Michael Bronstein, Ron Kimmel
Abstract: A method of transplanting undifferentiated hemopoietic stem cells into a recipient is provided. The method comprising the steps of: (a) expanding/maintaining the undifferentiated hemopoietic stem cells by: (i) obtaining the undifferentiated hemopoietic stem cells; and (ii) culturing the undifferentiated hemopoietic stem cells in a medium containing a stromal cell conditioned medium, the stromal cell conditioned medium being derived from a stationary phase plug-flow bioreactor in which a three dimensional stromal cell culture has been established under continuous flow on a substrate in the form of a sheet, the substrate including a non-woven fibrous matrix forming a physiologically acceptable three-dimensional network of fibers, thereby expanding the undifferentiated hemopoietic stem cells.
Type:
Application
Filed:
April 11, 2005
Publication date:
August 18, 2005
Applicant:
Technion Research & Development Foundation Ltd.
Abstract: A bioreactor plug comprising a container having an outlet and an inlet and containing therein a substrate in the form of a sheet, the substrate including a non-woven fibrous matrix forming a physiologically acceptable three-dimensional network of fibers, the substrate supporting at least 5×106 stromal cells per cubic centimeter of the substrate.
Type:
Application
Filed:
April 11, 2005
Publication date:
August 11, 2005
Applicant:
Technion Research & Development Foundation Ltd.
Abstract: A composition-of-matter comprising an antibody or antibody fragment including an antigen-binding region capable of specifically binding an antigen-presenting portion of a complex composed of a human antigen-presenting molecule and an antigen derived from a pathogen is disclosed.
Type:
Application
Filed:
March 9, 2005
Publication date:
July 14, 2005
Applicant:
Technion Research & Development Foundation Ltd.
Abstract: A method of expanding/maintaining undifferentiated hemopoietic stem cells or progenitor cells by obtaining undifferentiated hemopoietic stem cells or progenitor cells; and either seeding the undifferentiated hemopoietic stem cells or progenitor cells into a stationary phase plug-flow bioreactor in which a three-dimensional stromal cell culture has been pre-established on a substrate in the form of a sheet, the substrate including a non-woven fibrous matrix forming a physiologically acceptable three-dimensional network of fibers, thereby expanding/maintaining undifferentiated hemopoietic stem cells or progenitor cells, or culturing the undifferentiated hemopoietic stem cells or progenitor cells in conditioned medium obtained from such a reactor.
Type:
Grant
Filed:
February 4, 2000
Date of Patent:
June 28, 2005
Assignee:
Technion Research & Development Foundation Ltd.
Abstract: A compound having a general formula (II) wherein R1 is saturated or unsaturated alkyl, amino-alcohol, diamino, cycloalkyl, and C(?O)(CH2)nNR?R?, (CH2)nCHOHCH2NR?R?, wherein n is an integer, RQ, RT, R?, and R? are each independently a hydrogen, halogen, hydroxyl, saturated, unsaturated, aliphatic, or branched alkyl, substituted or unsubstituted (CH2)m-(hetero)aryl, and sulfonylamide; q and r are each an integer independently selected from 1-4; and pharmaceutically acceptable salts thereof, and the new therapeutic uses thereof and similar compounds as defibrillating, and/or anti-fibrillatory, and/or anti-arrhythmic and/or anti-ischemic drugs.
Type:
Grant
Filed:
August 27, 2000
Date of Patent:
June 21, 2005
Assignee:
Technion Research & Development Foundation Ltd.
Abstract: A piezoelectric device is disclosed, which includes a first element of porous crystalline material, a second element being attached to, or integrally formed with, the first element, and at least one electrode being in electrical contact with the first element, such that subjecting the first element to an electric potential via the at least one electrode results in a strain induced by the first element on the second element. Also disclosed is a piezooptic device which includes a first element of porous crystalline material, a second element being attached to, or integrally formed with, the first element, and a light source, such that subjecting the first element to light originating from the light source results in a strain induced by the first element on the second element.
Type:
Grant
Filed:
November 3, 2003
Date of Patent:
May 31, 2005
Assignee:
Technion Research & Development Foundation Ltd.
Abstract: Data processing apparatus is provided for evaluating answers to respective query items considered to be represented by respective points within a region of feature space, and the apparatus comprises an input (10) which receives such a query item. The region is subdivided into subregions according to at least first and second subdivisions. A subregion identifying portion (20) identifies, for each such subdivision of the region, which subregion of the subdivision contains the point representing the received query item. A partial answer retrieval portion (30) has access when the apparatus is in use to a store (40) of precalculated partial answers for at least some the subregions of the subdivisions, and retrieves from the store the partial answers for the or each identified subregion that is present in the store. An answer calculation portion (50) calculates an answer to the received query item based on the retrieved partial answers, and an output (60) outputs the calculated answer.
Type:
Grant
Filed:
March 7, 2002
Date of Patent:
April 26, 2005
Assignee:
Technion Research & Development Foundation Ltd.
Inventors:
Ilya Blayvas, Ron Kimmel, Alfred Bruckstein
Abstract: A method of identifying peptides originating from a particular cell type and being capable of binding to MHC molecules of a particular haplotype is disclosed. The method comprises obtaining a cell type expressing a soluble and secreted form of the MHC molecules of the particular haplotype; collecting the soluble and secreted form of the MHC molecules of the particular haplotype; and analyzing peptides bound to the soluble and secreted form of the MHC molecules of the particular haplotype, thereby identifying the peptides originating from the particular cell type and being capable of binding to MHC molecules of the particular haplotype.
Type:
Grant
Filed:
May 29, 2001
Date of Patent:
March 15, 2005
Assignee:
Technion Research & Development Foundation Ltd.
Inventors:
Eilon Barnea, Ilan Beer, Tamar Ziv, Arie Admon
Abstract: An antibody fragment and methods of utilizing same are provided. The antibody fragment includes an antigen binding region capable of binding an extracellular portion of a P-glycoprotein thereby at least partially inhibiting drug efflux activity in multidrug resistant cells.
Type:
Application
Filed:
April 2, 2003
Publication date:
October 7, 2004
Applicant:
Technion Research & Development Foundation Ltd.
Abstract: A piezoelectric device is disclosed, which includes a first element of porous crystalline material, a second element being attached to, or integrally formed with, the first element, and at least one electrode being in electrical contact with the first element, such that subjecting the first element to an electric potential via the at least one electrode results in a strain induced by the first element on the second element. Also disclosed is a piezooptic device which includes a first element of porous crystalline material, a second element being attached to, or integrally formed with, the first element, and a light source, such that subjecting the first element to light originating from the light source results in a strain induced by the first element on the second element.
Type:
Grant
Filed:
July 11, 2000
Date of Patent:
October 5, 2004
Assignee:
Technion Research & Development Foundation Ltd.
Abstract: A composition-of-matter comprising an antibody or antibody fragment including an antigen-binding region capable of specifically binding an antigen-presenting portion of a complex composed of a human antigen-presenting molecule and an antigen derived from a pathogen is disclosed.
Type:
Application
Filed:
March 26, 2003
Publication date:
September 30, 2004
Applicant:
Technion Research & Development Foundation Ltd.
Abstract: A method of preventing or reducing tobacco smoke-associated injury in the aerodigestive tract of a subject is disclosed. The method comprises administering a therapeutically effective amount of an antioxidant agent capable of preventing or reducing tobacco smoke-associated injury in the aerodigestive tract of a subject.
Type:
Grant
Filed:
November 15, 2001
Date of Patent:
September 14, 2004
Assignee:
Technion Research & Development Foundation Ltd.
Inventors:
Abraham Z. Reznick, Rafael M. Nagler, Ifat Klein
Abstract: A method of generating cultured chondrocytes/endochondral bone cells is disclosed. The method comprises isolating chondrocytes from mandibular condyle tissue, and culturing said isolated chondrocytes.
Type:
Application
Filed:
July 28, 2003
Publication date:
September 9, 2004
Applicant:
Technion Research & Development Foundation Ltd.
Abstract: A piezoelectric device is disclosed, which includes a first element of porous crystalline material, a second element being attached to, or integrally formed with, the first element, and at least one electrode being in electrical contact with the first element, such that subjecting the first element to an electric potential via the at least one electrode results in a strain induced by the first element on the second element. Also disclosed is a piezooptic device which includes a first element of porous crystalline material, a second element being attached to, or integrally formed with, the first element, and a light source, such that subjecting the first element to light originating from the light source results in a strain induced by the first element on the second element.
Type:
Grant
Filed:
February 1, 2002
Date of Patent:
April 27, 2004
Assignee:
Technion Research & Development Foundation Ltd.
Abstract: A cell culture comprising human foreskin cells, the human foreskin cells being capable of maintaining stem cells in an undifferentiated state when co-cultured therewith.
Type:
Application
Filed:
February 19, 2003
Publication date:
April 8, 2004
Applicant:
Technion Research & Development Foundation Ltd.